Quickly transform raw data into operational insights that support every kind of decision your organization makes. Reality-Tested AI.
Resilience Amid Uncertainty. Faster Outcomes, Trusted Results. Empowerment for Everyone. Read the story. See all customer stories. The Analytics Life Cycle SAS Viya takes you through every step of your analytics journey throughout the analytics life cycle — helping you make the most of your technology and talent investments.
Learn about the analytics life cycle. Learn about SAS Cloud. Azure Microsoft is our strategic partner and preferred cloud provider. Learn about SAS on Azure. Read report. Get e-book. Try it for free. Int J Cancer. PubMed Google Scholar Crossref. Global cancer statistics, CA Cancer J Clin. Global cancer statistics.
Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. PubMed Google Scholar. New agents on the horizon in gastric cancer.
Ann Oncol. National Comprehensive Cancer Network. Accessed December 5, Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Abdel-Rahman O. Immune checkpoints aberrations and gastric cancer: assessment of prognostic value and evaluation of therapeutic potentials. Crit Rev Oncol Hematol. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
J Exp Med. Lancet Oncol. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. National Cancer Institute. Common terminology criteria for adverse events v4. The use of confidence or fiducial limits illustrated in the case of binomial. Google Scholar Crossref.
Development and analytical performance of a molecular diagnostic for anti-PD1 response on the nCounter Dx Analysis System. J Clin Oncol. J Clin Invest. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma KEYNOTE : a randomised, controlled, phase 2 trial. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer KEYNOTE : a non-randomised, open-label, phase 1b study. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck KEYNOTE : an open-label, multicentre, phase 1b trial. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer—a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie AIO.
Eur J Cancer. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma COUGAR : an open-label, phase 3 randomised controlled trial. Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG trial.
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma RAINBOW : a double-blind, randomised phase 3 trial. A phase I multi-arm dose-expansion study of the anti-programmed cell death-ligand-1 PD-L1 antibody media preliminary data.
National Institutes of Health. Save Preferences. Privacy Policy Terms of Use. View Correction. This Issue. Views 56, Citations View Metrics. Twitter Facebook More LinkedIn. Original Investigation. Charles S. Jalal, MD 10 ; Manish A.
Wainberg, MD 17 ; Daniel V. Yoon, MD Key Points Question Is pembrolizumab monotherapy safe and effective in patients with previously treated gastric and gastroesophageal junction cancer? Every day is Giving Tuesday when crop science meets data science.
How analytics is helping with climate sustainability. Unemployment fraud meets analytics: Fighting back to protect citizens. What does it take to become an analytics-driven demand-planning organization?
Curiosity Work. Curiosity has never been more valuable to leaders. Tableau's software moves as fast as you do. Learn more. If I didn't start using Tableau, I would still be using Excel. I would still have a fear of data. And then I wouldn't have a bigger view of how data can help in my day-to-day work. Before, it was always numbers in rows and columns.
More customer stories. Go to pricing. Register for a live demo. Buy Now. Get actionable insights fast Leave chart builders behind. Start a free trial. Connect to hundreds of data sources.
0コメント